EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The inhibitors of miR-224-5p, miR-339-5p, and miR-1198-5p improve auditory function by promoting the expression of neuritin in hearing loss mice

Pingping Meng, Zhiwei Zhong, Yin Song, Yu Wei, Jiawei Sun, Jingyi Chen, Yunhua Zhang, Jingling Zhu iD

PLOS One · 21.05.2026 · 21 (5) · e0349821

DOI: 10.1371/journal.pone.0349821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 21.05.2026. Verfasst von Pingping Meng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, The Key Laboratory of Xinjiang Endemic & Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China. Hauptthemen laut MEDLINE: MicroRNAs, Neuropeptides, Hearing Loss, Sensorineural. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: science and technology program of XPCC, High-level Talent Research Start-up Project of Shihezi University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sensorineural hearing loss (SNHL) is the main type of hearing impairment, and currently there is a lack of effective preventive or therapeutic drugs. Our previous research revealed that the expression of neurotrophic factor Neuritin decreased in hearing loss. After treatment with recombinant human Neuritin protein, the number of hair cells significantly increased. However, the molecular mechanism underlying the decreased expression of Neuritin in hearing loss remains unclear. Research indicates that Neuritin expression is regulated by microRNAs (miRNAs). This study aims to screen and validate the key miRNAs that regulate the expression of Neuritin and assess the feasibility of these miRNAs as therapeutic targets for SNHL.

Methods

This study utilized a mouse model of SNHL and employed high-throughput sequencing and bioinformatics analysis to screen for miRNAs that regulate the expression of neurofilament proteins in cochlear tissues. Subsequently, in vivo experiments were conducted to verify the regulatory effects of the candidate miRNAs on neurofilament proteins and to evaluate the improvement of SNHL by the corresponding miRNA inhibitors.

Results

After screening and identification, three miRNAs specifically inhibiting the expression of neurofilament protein were obtained, namely miR-224-5p, miR-339-5p and miR-1198-5p. The in vivo experimental results indicated that the inhibitors of the above three miRNAs had a significant improvement effect on the SNHL mouse model.

Conclusion

MiR-224-5p, miR-339-5p and miR-1198-5p can be involved in the pathogenesis of SNHL by regulating the expression of neurofilament proteins. Targeting these miRNAs or their inhibitors can provide new molecular targets and strategies for the prevention and treatment of SNHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeuropeptidesHearing Loss, SensorineuralAnimalsMiceGPI-Linked ProteinsDisease Models, AnimalGene Expression RegulationNeurofilament ProteinsCochleaMice, Inbred C57BLMaleHumansNerve Tissue Proteins

Substanzen

MicroRNAsGPI-Linked ProteinsNrn1 protein, mouseNeuropeptidesNeurofilament ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, The Key Laboratory of Xinjiang Endemic & Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
  • Jiaxing Key Laboratory of Pathogenic Microbiology, Jiaxing Center for Disease Control and Prevention, Jiaxing, Zhejiang, China.
  • First Affiliated Hospital of Shihezi University School of Medicine, Shihezi, Xinjiang, China.

ORCID-Profile: Jingling Zhu

Förderung

  • science and technology program of XPCC
  • High-level Talent Research Start-up Project of Shihezi University
  • National Natural Science Foundation of China

Zitieren

APA

Meng, P., Zhong, Z., Song, Y., Wei, Y., Sun, J., Chen, J., Zhang, Y., & Zhu, J. (2026). The inhibitors of miR-224-5p, miR-339-5p, and miR-1198-5p improve auditory function by promoting the expression of neuritin in hearing loss mice. PLOS One, 21(5), e0349821. https://doi.org/10.1371/journal.pone.0349821

Vancouver

Meng P, Zhong Z, Song Y, Wei Y, Sun J, Chen J, et al. The inhibitors of miR-224-5p, miR-339-5p, and miR-1198-5p improve auditory function by promoting the expression of neuritin in hearing loss mice. PLOS One. 2026;21(5):e0349821. doi:10.1371/journal.pone.0349821

BibTeX
@article{Meng2026,
  author = {Meng, Pingping and Zhong, Zhiwei and Song, Yin and Wei, Yu and Sun, Jiawei and Chen, Jingyi and Zhang, Yunhua and Zhu, Jingling},
  title = {The inhibitors of miR-224-5p, miR-339-5p, and miR-1198-5p improve auditory function by promoting the expression of neuritin in hearing loss mice},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {e0349821},
  doi = {10.1371/journal.pone.0349821}
}
Kostenlos starten →